Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
WOK Stock Forecast 2026-2027
$0.09
Current Price
$97,584
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to WOK Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
WOK Price Momentum
-10.0%
1 Week Change
-86.4%
1 Month Change
-100.0%
1 Year Change
-95.9%
Year-to-Date Change
-100.0%
From 52W High of $9,300.00
+45.3%
From 52W Low of $0.06
📊 TOP ANALYST CALLS
Did WOK Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if WORK Medical is one of their latest high-conviction picks.
Latest WOK Stock Price Targets & Analyst Predictions
WOK has shown a year-to-date change of -95.9% and a 1-year change of -100.0%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for WOK. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
WOK Analyst Ratings
0
Buy
0
Hold
0
Sell
WOK Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $0.09
Latest WOK Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for WOK.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Work Medical Technology Group Inc. (WOK) Competitors
The following stocks are similar to WORK Medical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Work Medical Technology Group Inc. (WOK) Financial Data
Valuation Metrics
Market Cap
$97,584
Enterprise Value
$5.25M
P/E Ratio
N/A
PEG Ratio
N/A
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
-14.4%
Gross Margin
N/A
Operating Margin
-17.5%
Net Margin
-10.9%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+3,910.2%
Current Ratio
1.7x
Debt/Equity
30.3x
ROE
-6.5%
ROA
-4.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Work Medical Technology Group Inc. (WOK) Business Model
About Work Medical Technology Group Inc.
What They Do
Manufactures disposable medical consumables and devices.
Business Model
The company generates revenue by manufacturing and selling a wide range of disposable medical products, particularly in respiratory and anesthesia equipment. It serves healthcare providers globally, providing essential items that enhance patient safety and operational efficiency in medical settings.
Additional Information
Founded in 2022 and based in Hangzhou, China, the company exports to approximately 30 countries across various continents, highlighting its international reach within the health technology sector.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
238
CEO
Mr. Shuang Wu
Country
China
IPO Year
N/A
Website
www.workmedtech.comWork Medical Technology Group Inc. (WOK) Latest News & Analysis
Latest News
Quick Summary
WORK Medical Technology Group LTD (Nasdaq: WOK) participated in the 2026 CBA-China Annual Conference, enhancing its engagement with the global biopharmaceutical community.
Why It Matters
WORK Medical's participation in a major biopharmaceutical conference signals potential partnerships and innovation, which could enhance its market position and attract investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
WORK Medical Technology Group LTD has launched its U.S. subsidiary, Work Bio Technologies Ltd, to enhance its global operations and market development strategy.
Why It Matters
Establishing a U.S. subsidiary enhances WORK Medical's market presence and growth potential, signaling confidence in expansion and possibly increasing investor interest and stock value.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
WORK Medical Technology Group LTD has signed a strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to enhance its medical device offerings in China.
Why It Matters
WORK Medical's strategic partnership with Novabioplus could enhance its product offerings and market position, potentially driving revenue growth and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
WORK Medical Technology Group (Nasdaq: WOK) has been awarded a Council Member certificate as a Vice President Unit of the Hong Kong Web3.0 Standardization Association, enhancing its industry standing in Web3.0.
Why It Matters
WORK Medical's recognition in the Web3.0 sector may enhance its credibility and partnerships, potentially leading to growth opportunities in the rapidly evolving tech landscape.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
WORK Medical Technology Group's subsidiary, Hunan Saitumofei, received manufacturing approval for its AI-Automated Blood Cell Analyzer, marking a significant step in its growth strategy.
Why It Matters
The approval of the AI-Automated Blood Cell Morphology Analyzer enhances WORK Medical's product portfolio, potentially driving revenue growth and increasing market competitiveness in the medical device sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
WORK Medical Technology Group announced a one-year exclusive distribution agreement with Shanghai Benke to promote its AI-Automated Blood Cell Morphology Analyzer in East China throughout 2026.
Why It Matters
The exclusive distribution agreement enhances WORK Medical's market position in East China, potentially boosting revenue and growth prospects through the commercialization of innovative technology.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About WOK Stock
What is Work Medical Technology Group Inc.'s (WOK) stock forecast for 2026?
Analyst forecasts for Work Medical Technology Group Inc. (WOK) are not currently available. The stock is trading at $0.09.
Is WOK stock a good investment in 2026?
Analyst ratings for WOK are not currently available. The stock is currently trading at $0.09. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for WOK stock?
Price predictions from Wall Street analysts for WOK are not currently available. The stock is trading at $0.09.
What is Work Medical Technology Group Inc.'s business model?
The company generates revenue by manufacturing and selling a wide range of disposable medical products, particularly in respiratory and anesthesia equipment. It serves healthcare providers globally, providing essential items that enhance patient safety and operational efficiency in medical settings.
What is the highest forecasted price for WOK Work Medical Technology Group Inc.?
Price targets from Wall Street analysts for WOK are not currently available. The stock is trading at $0.09.
What is the lowest forecasted price for WOK Work Medical Technology Group Inc.?
Price targets from Wall Street analysts for WOK are not currently available. The stock is trading at $0.09.
What is the overall WOK consensus from analysts for Work Medical Technology Group Inc.?
Analyst ratings for WOK are not currently available. The stock is trading at $0.09.
How accurate are WOK stock price projections?
Stock price projections, including those for Work Medical Technology Group Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 16, 2026 4:08 AM UTC